Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment (Q35746110)
Jump to navigation
Jump to search
scientific article published on 4 May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment |
scientific article published on 4 May 2015 |
Statements
1 reference
Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment (English)
1 reference
Guo-Jun Li
1 reference
Yi-Qi Yu
1 reference
Shao-Long Chen
1 reference
Ping Fan
1 reference
Ling-Yun Shao
1 reference
Jia-Zhen Chen
1 reference
Chang-Shui Li
1 reference
Bin Yi
1 reference
Wei-Cun Chen
1 reference
Shu-Yuan Xie
1 reference
Xiao-Na Mao
1 reference
He-Hui Zou
1 reference
Wen-Hong Zhang
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference